mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.04 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.04 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |